From Venom to Vein: Factor VII Activation as a Major Pathophysiological Target for Procoagulant Australian Elapid Snake Venoms
Toxins · 2024
DOI: 10.3390/toxins16100430 ↗Kurz gefasst
Fachartikel in der Zeitschrift Toxins, 2024. Verfasst von Uthpala Chandrasekara und 5 weiteren Autor:innen. Beteiligte Einrichtung: Adaptive Biotoxicology Lab, School of the Environment, University of Queensland, St. Lucia, QLD 4072, Australia. Hauptthemen laut MEDLINE: Elapid Venoms, Prothrombin, Elapidae, Blood Coagulation. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Australian Research Council, Australian Research Council Discovery Project.
Abstract (Originalsprache)
Australian elapid snake venoms are uniquely procoagulant, utilizing blood clotting enzyme Factor Xa (FXa) as a toxin, which evolved as a basal trait in this clade. The subsequent recruitment of Factor Va (FVa) as a toxin occurred in the last common ancestor of taipans (Oxyuranus species) and brown snakes (Pseudonaja species). Factor II (prothrombin) activation has been stated as the primary mechanism for the lethal coagulopathy, but this hypothesis has never been tested. The additional activation of Factor VII (FVII) by Oxyuranus/Pseudonaja venoms has historically been considered as a minor, unimportant novelty. This study aimed to investigate the significance of toxic FVII activation relative to prothrombin activation by testing a wide taxonomical range of Australian elapid species with procoagulant venoms. The activation of FVII or prothrombin, with and without the Factor Va as a cofactor, was assessed, along with the structural changes involved in these processes. All procoagulant species could activate FVII, establishing this as a basal trait. In contrast, only some lineages could activate prothrombin, indicating that this is a derived trait. For species able to activate both zymogens, Factor VII was consistently more strongly activated than prothrombin. FVa was revealed as an essential cofactor for FVII activation, a mechanism previously undocumented. Species lacking FVa in their venom utilized endogenous plasma FVa to exert this activity. The ability of the human FXa:FVa complex to activate FVII was also revealed as a new feedback loop in the endogenous clotting cascade. Toxin sequence analyses identified structural changes essential for the derived trait of prothrombin activation. This study presents a paradigm shift in understanding how elapid venoms activate coagulation factors, highlighting the critical role of FVII activation in the pathophysiological effects upon the coagulation cascade produced by Australian elapid snake venoms. It also documented the novel use of Factor Va as a cofactor for FVII activation for both venom and endogenous forms of FXa. These findings are crucial for developing better antivenoms and treatments for snakebite victims and have broader implications for drug design and the treatment of coagulation disorders. The research also advances the evolutionary biology knowledge of snake venoms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Adaptive Biotoxicology Lab, School of the Environment, University of Queensland, St. Lucia, QLD 4072, Australia.
- School of the Environment, University of Queensland, St. Lucia, QLD 4072, Australia.
- Venom Supplies Pty Ltd., Stonewell Rd., Tanunda, SA 5352, Australia.
ORCID-Profile: Christina N Zdenek, Nathan Dunstan, Bryan G Fry
Förderung
- Australian Research Council
- Australian Research Council Discovery Project
Zitieren
APA
Chandrasekara, U., Chowdhury, A., Seneci, L., Zdenek, C. N., Dunstan, N., & Fry, B. G. (2024). From Venom to Vein: Factor VII Activation as a Major Pathophysiological Target for Procoagulant Australian Elapid Snake Venoms. Toxins. https://doi.org/10.3390/toxins16100430
Vancouver
Chandrasekara U, Chowdhury A, Seneci L, Zdenek CN, Dunstan N, Fry BG. From Venom to Vein: Factor VII Activation as a Major Pathophysiological Target for Procoagulant Australian Elapid Snake Venoms. Toxins. 2024. doi:10.3390/toxins16100430
BibTeX
@article{Chandrasekara2024,
author = {Chandrasekara, Uthpala and Chowdhury, Abhinandan and Seneci, Lorenzo and Zdenek, Christina N and Dunstan, Nathan and Fry, Bryan G},
title = {From Venom to Vein: Factor VII Activation as a Major Pathophysiological Target for Procoagulant Australian Elapid Snake Venoms},
journal = {Toxins},
year = {2024},
doi = {10.3390/toxins16100430}
}
EUVIMED